Boston Scientific to buy California heart device startup

Cryterion Medical is developing a treatment for atrial fibrillation, or irregular heartbeat. Boston Scientific has been an investor in the company since it was launched in 2016.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.